TiVo strikes European licensing deal with Fnac Darty
The multi-region European intellectual property license enables Fnac Darty to deploy patented TiVo innovations in its own branded set-top box (STB) and TV products.
The deal, announced yesterday, May 16, covers the consumer electronics brands of Fnac Darty, which is based in France and operates in 11 countries licence enables Fnac Darty to enhance its own branded set-top box and TV products with TiVo’s patented technology.
According to the TiVo announcement, the “multi-region” European IP licence enables Fnac Darty to enhance its own branded set-top box and TV products with TiVo’s patented technology.”
“TiVo’s engagement with Fnac Darty demonstrates our leadership in delivering the ultimate entertainment experience to consumers across Europe,” said Arvin Patel, executive vice president and chief IP officer, Rovi Corporation, a TiVo company. “It is testament to our broad patent portfolios and innovations that are increasingly important to advanced search and discovery in the consumer electronics market. We’re pleased to help Fnac Darty expand its offerings and grow its customer base with our innovations.”
Earlier this year, WIPR interviewed Patel about licensing at TiVo, which has nine of the top ten pay-to-watch TV companies on its licensee list.
In the interview, Patel revealed that TiVo has more than 5,000 issued and pending patents, in addition to its 750trademarks worldwide. This compares to the 3,000 patents owned by entertainment industry participants Dish and Comcast, and the nearly 18,000 owned by AT&T, which include many patents beyond media and entertainment.
In 2016, TiVo agreed to be acquired by Rovi for $1.1 billion.
France-headquartered Fnac Darty is a European retailer of entertainment and leisure products, consumer electronics and household appliances. As of December 2017 the company had 728 stores, including 502 in France.
Source: world intellectual property reviewPrevious Post Next Post
- Powering Change: Women in innovation and Creativity
- Rapid Growth in Trademarks in China
- Nasal Spray Patents Covering Migraine Drug Zomig Not Invalid As Obvious
- Oprah Winfrey sued for Plagiarism
- Understanding U.S. Patent Prosecution